サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1773777

組換えタンパク質の世界市場：産業分析、規模、シェア、成長、動向、予測、2025年～2032年

Recombinant Proteins Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 195 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.53円
組換えタンパク質の世界市場：産業分析、規模、シェア、成長、動向、予測、2025年～2032年
出版日: 2025年07月15日
発行: Persistence Market Research
ページ情報: 英文 195 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、組換えタンパク質の世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題などの重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。この調査レポートは、2025年～2032年の世界の組換えタンパク質市場の予測成長軌道を概説する独占データと統計を掲載しています。

主な洞察

  • 組換えタンパク質の市場規模（2025年）：16億520万米ドル
  • 予測市場金額（2032年）：28億1,320万米ドル
  • 世界市場成長率（CAGR 2025～2032年）：8.3%

組換えタンパク質市場 - レポート範囲：

組換えタンパク質は、様々な治療、診断、研究用途で重要な役割を果たしています。遺伝子工学技術によって生産されたこれらのタンパク質は、疾患の標的治療を可能にし、ワクチン開発をサポートし、バイオテクノロジーと分子生物学の先端研究を促進します。組換えタンパク質市場は、製薬・バイオテクノロジー産業、学術・研究機関、診断研究所、研究・製造受託機関向けに供給されています。市場成長の原動力は、生物製剤に対する需要の増加、個別化医療における用途の拡大、タンパク質発現システムの技術的進歩による組換えタンパク質の収率、純度、機能性の向上です。

市場成長促進要因：

世界の組換えタンパク質市場は、慢性疾患や感染症の流行が増加し、生物学的療法や診断ツールの需要が高まっていることなど、いくつかの重要な要因によって推進されています。バイオテクノロジー研究開発への投資の増加と遺伝子編集および細胞培養技術の進歩により、組換えタンパク質生産の効率性と拡張性が大幅に向上しています。さらに、COVID-19パンデミックの際に顕著であった、ワクチン開発における組換えタンパク質の採用の増加は、現代の治療法における組換えタンパク質の重要な役割を浮き彫りにしています。再生医療、腫瘍学、免疫療法における組換えタンパク質の使用範囲の拡大は、製薬会社がアンメット・メディカル・ニーズに対応するために新規の生物製剤を求めていることから、市場の成長をさらに刺激しています。

市場抑制要因：

有望な成長が見込まれる一方で、組換えタンパク質市場は、高い生産コスト、複雑な製造工程、生物製剤に適用される厳しい規制要件に関連する課題に直面しています。組換えタンパク質の開発には多大な時間と投資が必要となることが多く、新規市場参入企業や小規模なバイオテクノロジー企業にとっては障壁となります。さらに、組換えタンパク質の免疫原性、安定性、拡張性などの問題は、製品の有効性や安全性に影響を及ぼす可能性があり、厳格な品質管理とバリデーション・プロトコルが必要となります。また、特定の地域、特にコストに敏感な新興市場における生物製剤の価格圧力や償還の不確実性も、広く市場に浸透するための課題となっています。これらのハードルを克服するには、技術革新、戦略的提携、そして組換えタンパク質をベースとしたソリューションへの幅広いアクセスを確保するための規制経路の合理化が必要です。

市場機会：

組換えタンパク市場は、精密医療、先端治療薬、バイオテクノロジー研究への応用拡大により、大きな成長機会をもたらしています。安定性、有効性が向上し、免疫原性が低下した次世代組換えタンパク質の開発により、がんや自己免疫疾患などの複雑な疾患への治療介入に新たな道が開かれます。合成生物学、CRISPRベースの遺伝子編集、植物ベースや無細胞プラットフォームのような新しい発現システムなどの新しい技術は、生産コストを下げ、スケーラビリティを向上させる革新的なアプローチを提供します。さらに、バイオシミラー、診断薬、新規ワクチンプラットフォームの開発における組換えタンパク質の需要の高まりは、市場開拓者にとって有利な機会を生み出しています。戦略的パートナーシップ、研究開発への投資、費用対効果の高い組換えタンパク質ソリューションの競合情勢は、進化する市場情勢を捉え、競争優位性を維持する上で極めて重要です。

本レポートで扱う主な質問

  • 組換えタンパク質市場の世界的成長を促進する主な要因は何か？
  • 製薬、診断、研究の各分野で採用が進んでいる組換えタンパク質の種類と用途は？
  • 技術の進歩は組換えタンパク質市場の競合情勢をどのように変えているのか？
  • 組換えタンパク質市場に貢献している主要企業はどこで、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 組換えタンパク質の世界市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主な動向
  • マクロ経済要因
    • 世界のセクター別展望
    • 世界のGDP成長見通し
  • COVID-19の影響分析
  • 予測要因：関連性と影響

第3章 付加価値のある洞察

  • 規制状況
  • 製品採用分析
  • 現在の治療用タンパク質発現システムの利点と欠点
  • 組換えタンパク質の主要サプライヤーリスト（地域別）
  • メーカーの主なプロモーション戦略
  • バリューチェーン分析
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 価格動向分析、2019～2032年

  • 主なハイライト
  • 製品価格に影響を与える主な要因
  • 製品タイプ別の価格分析
  • 地域価格と製品の嗜好

第5章 世界の組換えタンパク質市場の展望

  • 主なハイライト
    • 市場予測
    • 市場規模と前年比成長率
    • 絶対的収益機会
  • 市場規模分析と予測
    • 過去の市場規模分析（2019年～2024年）
    • 現在の市場規模分析・予測（2025年～2032年）
  • 世界の組換えタンパク質市場の展望：製品タイプ
    • イントロダクション/主な調査結果
    • 過去の市場規模分析：製品タイプ別（2019年～2024年）
    • 現在の市場規模分析・予測：製品タイプ別（2025年～2032年）
      • ホルモン
      • サイトカインと成長因子
      • 免疫チェックポイントタンパク質
      • 代謝酵素
      • 抗体
      • 調節タンパク質
      • 構造タンパク質
      • コラーゲン
      • その他
    • 市場の魅力分析：製品タイプ
  • 世界の組換えタンパク質市場の展望：組換えタンパク質発現システム
    • イントロダクション/主な調査結果
    • 過去の市場規模分析：組換えタンパク質発現システム別（2019年～2024年）
    • 現在の市場規模分析・予測：組換えタンパク質発現システム別（2025年～2032年）
      • 哺乳類発現システム
      • 細菌発現システム
      • 酵母発現システム
      • 昆虫細胞発現システム
      • その他
    • 市場の魅力分析：組換えタンパク質発現システム
  • 世界の組換えタンパク質市場の展望：用途
    • イントロダクション/主な調査結果
    • 過去の市場規模分析：用途別（2019年～2024年）
    • 現在の市場規模分析・予測：用途別（2025年～2032年）
      • 生物医学研究
      • 診断と治療
      • 医薬品の創薬と開発
      • 食品用途
      • 化粧品用途
      • その他
  • 市場の魅力分析：用途
  • 世界の組換えタンパク質市場の展望：エンドユーザー
    • イントロダクション/主な調査結果
    • 過去の市場規模分析：エンドユーザー別（2019年～2024年）
    • 現在の市場規模分析・予測：エンドユーザー別（2025年～2032年）
      • バイオ医薬品企業
      • 契約研究機関
      • 学術研究機関
      • 診断検査室
      • 食品業界
      • 化粧品業界
      • その他
  • 市場の魅力分析：エンドユーザー

第6章 世界の組換えタンパク質市場の展望：地域

  • 主なハイライト
  • 過去の市場規模分析：地域別（2019年～2024年）
  • 現在・将来の市場規模分析・予測：地域別（2025年～2032年）
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第7章 北米の組換えタンパク質市場の展望

第8章 欧州の組換えタンパク質市場の展望

第9章 東アジアの組換えタンパク質市場の展望

第10章 南アジア・オセアニアの組換えタンパク質市場の展望

第11章 ラテンアメリカの組換えタンパク質市場の展望

第12章 中東・アフリカの組換えタンパク質市場の展望

第13章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
    • 競合激化マップ：市場別
    • 競合ダッシュボード
  • 企業プロファイル（詳細：概要、財務、戦略、最近の開発）
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Sino Biological
    • GenScript
    • Bio-Rad Laboratories, Inc
    • STEMCELL Technologies
    • FUJIFILM Irvine Scientific
    • Rockland Immunochemical
    • ACROBiosystems
    • Miltenyi Biotec
    • Bio-Techne
    • Proteintech Group, Inc.
    • Enzo Biochem Inc.
    • RayBiotech, Inc.
    • BioLegend, Inc.
    • Abcam Limited
    • SYNBIO Technologies
    • BPS Bioscience, Inc.
    • Revvity
    • Creative BioMart
    • G-Biosciences（Geno Technology Inc.）
    • Bioxcell
    • Corning Incorporated
    • Biosensis Pty Ltd.

第14章 付録

  • 調査手法
  • 調査の前提条件
  • 頭字語と略語
目次
Product Code: PMRREP35462

Persistence Market Research has recently released a comprehensive report on the worldwide market for recombinant proteins. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global recombinant proteins market from 2025 to 2032.

Key Insights:

  • Recombinant Proteins Market Size (2025E): USD 1,605.2 Million
  • Projected Market Value (2032F): USD 2,813.2 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.3%

Recombinant Proteins Market - Report Scope:

Recombinant proteins play a crucial role across various therapeutic, diagnostic, and research applications. Produced through genetic engineering techniques, these proteins enable targeted treatments for diseases, support vaccine development, and facilitate advanced research in biotechnology and molecular biology. The recombinant proteins market caters to the pharmaceutical and biotechnology industries, academic and research institutions, diagnostic laboratories, and contract research and manufacturing organizations. Market growth is driven by increasing demand for biologics, expanding applications in personalized medicine, and technological advancements in protein expression systems, leading to higher yields, purity, and functionality of recombinant proteins.

Market Growth Drivers:

The global recombinant proteins market is propelled by several key factors, including rising prevalence of chronic and infectious diseases, fueling demand for biologic therapies and diagnostic tools. Growing investments in biotechnology research and development, coupled with advancements in gene editing and cell culture technologies, have significantly enhanced the efficiency and scalability of recombinant protein production. Additionally, the increasing adoption of recombinant proteins in vaccine development, notably evident during the COVID-19 pandemic, has underscored their critical role in modern therapeutics. The expanding scope of recombinant proteins in regenerative medicine, oncology, and immunotherapy further stimulates market growth, as pharmaceutical companies seek novel biologics to address unmet medical needs.

Market Restraints:

Despite promising growth prospects, the recombinant proteins market faces challenges related to high production costs, complex manufacturing processes, and stringent regulatory requirements governing biologics. The development of recombinant proteins often entails significant time and investment, posing barriers for new market entrants and smaller biotech firms. Furthermore, issues such as immunogenicity, stability, and scalability of recombinant proteins can affect product efficacy and safety, requiring rigorous quality control and validation protocols. Pricing pressures and reimbursement uncertainties for biologics in certain regions, particularly in cost-sensitive emerging markets, also pose challenges to widespread market penetration. Overcoming these hurdles necessitates innovation, strategic collaborations, and streamlined regulatory pathways to ensure broader access to recombinant protein-based solutions.

Market Opportunities:

The recombinant proteins market presents significant growth opportunities driven by expanding applications in precision medicine, advanced therapeutics, and biotechnology research. The development of next-generation recombinant proteins with enhanced stability, efficacy, and reduced immunogenicity opens new avenues for therapeutic interventions in complex diseases such as cancer and autoimmune disorders. Emerging technologies, including synthetic biology, CRISPR-based gene editing, and novel expression systems like plant-based or cell-free platforms, offer innovative approaches to lower production costs and improve scalability. Additionally, growing demand for recombinant proteins in the development of biosimilars, diagnostics, and novel vaccine platforms creates lucrative opportunities for market players. Strategic partnerships, investments in R&D, and the commercialization of cost-effective recombinant protein solutions will be pivotal in capturing the evolving market landscape and sustaining competitive advantage.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the recombinant proteins market globally?
  • Which recombinant protein types and applications are driving adoption across pharmaceutical, diagnostic, and research sectors?
  • How are technological advancements reshaping the competitive landscape of the recombinant proteins market?
  • Who are the key players contributing to the recombinant proteins market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global recombinant proteins market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in research and development to produce high-quality recombinant proteins for therapeutics, diagnostics, and research applications. Collaborations with pharmaceutical companies, academic institutions, and contract manufacturing organizations facilitate technology transfer, accelerate product development, and enhance market reach. Additionally, emphasis on improving manufacturing efficiency, ensuring regulatory compliance, and expanding product portfolios helps market leaders address diverse customer needs and maintain competitiveness in the rapidly evolving biotechnology landscape.

Key Companies Profiled:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Sino Biological
  • GenScript
  • Bio-Rad Laboratories, Inc
  • STEMCELL Technologies
  • FUJIFILM Irvine Scientific
  • Rockland Immunochemical
  • ACROBiosystems
  • Miltenyi Biotec
  • Bio-Techne
  • Proteintech Group, Inc.
  • Enzo Biochem Inc.
  • RayBiotech, Inc.
  • BioLegend, Inc.
  • Abcam Limited
  • SYNBIO Technologies
  • BPS Bioscience, Inc.
  • Revvity
  • Creative BioMart
  • G-Biosciences (Geno Technology Inc.)
  • Bioxcell
  • Corning Incorporated
  • Biosensis Pty Ltd.
  • Others

Recombinant Proteins Market Research Segmentation:

The recombinant proteins market encompasses a diverse range of products, applications, and end-user segments, addressing various therapeutic, diagnostic, and research needs.

By Product Type:

  • Hormones
  • Cytokines and Growth Factors
  • Immune Checkpoint Proteins
  • Metabolic Enzymes
  • Antibodies
  • Regulatory Proteins
  • Structural Proteins
  • Collagen
  • Others

By Recombinant Protein Expression Systems:

  • Mammalian Expression Systems
  • Bacterial Expression Systems
  • Yeast Expression Systems
  • Insect Cells Expression Systems
  • Others

By Application:

  • Biomedical Research
  • Diagnostics and Therapeutics
  • Drug Discovery and Development
  • Food Application
  • Cosmetic Application
  • Others

By End User:

  • Biopharma Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Food Industry
  • Cosmetic Industry
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Recombinant Proteins Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Advantages and Disadvantages of Current Therapeutic Protein Expression Systems
  • 3.4. List of Key Suppliers of Recombinant Proteins, By Region
  • 3.5. Key Promotional Strategies by Manufacturers
  • 3.6. Value Chain Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product Type
  • 4.4. Regional Prices and Product Preferences

5. Global Recombinant Proteins Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Recombinant Proteins Market Outlook: Product Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Analysis, By Product Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
      • 5.3.3.1. Hormones
      • 5.3.3.2. Cytokines and Growth Factors
      • 5.3.3.3. Immune Checkpoint Proteins
      • 5.3.3.4. Metabolic Enzymes
      • 5.3.3.5. Antibodies
      • 5.3.3.6. Regulatory Proteins
      • 5.3.3.7. Structural Proteins
      • 5.3.3.8. Collagen
      • 5.3.3.9. Others
    • 5.3.4. Market Attractiveness Analysis: Product Type
  • 5.4. Global Recombinant Proteins Market Outlook: Recombinant Protein Expression Systems
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) and Analysis, By Recombinant Protein Expression Systems, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
      • 5.4.3.1. Mammalian Expression Systems
      • 5.4.3.2. Bacterial Expression Systems
      • 5.4.3.3. Yeast Expression Systems
      • 5.4.3.4. Insect Cells Expression Systems
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Product Type
  • 5.5. Global Recombinant Proteins Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.5.3.1. Biomedical Research
      • 5.5.3.2. Diagnostics and Therapeutics
      • 5.5.3.3. Drug Discovery and Development
      • 5.5.3.4. Food Application
      • 5.5.3.5. Cosmetic Application
      • 5.5.3.6. Others
  • 5.6. Market Attractiveness Analysis: Application
  • 5.7. Global Recombinant Proteins Market Outlook: End User
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.7.3.1. Biopharma Companies
      • 5.7.3.2. Contract Research Organizations
      • 5.7.3.3. Academic Research Institutes
      • 5.7.3.4. Diagnostic Laboratories
      • 5.7.3.5. Food Industry
      • 5.7.3.6. Cosmetic Industry
      • 5.7.3.7. Others
  • 5.8. Market Attractiveness Analysis: End User

6. Global Recombinant Proteins Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) and Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Recombinant Proteins Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Recombinant Protein Expression Systems
    • 7.2.4. By Application
    • 7.2.5. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Hormones
    • 7.4.2. Cytokines and Growth Factors
    • 7.4.3. Immune Checkpoint Proteins
    • 7.4.4. Metabolic Enzymes
    • 7.4.5. Antibodies
    • 7.4.6. Regulatory Proteins
    • 7.4.7. Structural Proteins
    • 7.4.8. Collagen
    • 7.4.9. Others
  • 7.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
    • 7.5.1. Mammalian Expression Systems
    • 7.5.2. Bacterial Expression Systems
    • 7.5.3. Yeast Expression Systems
    • 7.5.4. Insect Cells Expression Systems
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Biomedical Research
    • 7.6.2. Diagnostics and Therapeutics
    • 7.6.3. Drug Discovery and Development
    • 7.6.4. Food Application
    • 7.6.5. Cosmetic Application
    • 7.6.6. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Biopharma Companies
    • 7.7.2. Contract Research Organizations
    • 7.7.3. Academic Research Institutes
    • 7.7.4. Diagnostic Laboratories
    • 7.7.5. Food Industry
    • 7.7.6. Cosmetic Industry
    • 7.7.7. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Recombinant Proteins Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Recombinant Protein Expression Systems
    • 8.2.4. By Application
    • 8.2.5. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Hormones
    • 8.4.2. Cytokines and Growth Factors
    • 8.4.3. Immune Checkpoint Proteins
    • 8.4.4. Metabolic Enzymes
    • 8.4.5. Antibodies
    • 8.4.6. Regulatory Proteins
    • 8.4.7. Structural Proteins
    • 8.4.8. Collagen
    • 8.4.9. Others
  • 8.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
    • 8.5.1. Mammalian Expression Systems
    • 8.5.2. Bacterial Expression Systems
    • 8.5.3. Yeast Expression Systems
    • 8.5.4. Insect Cells Expression Systems
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Biomedical Research
    • 8.6.2. Diagnostics and Therapeutics
    • 8.6.3. Drug Discovery and Development
    • 8.6.4. Food Application
    • 8.6.5. Cosmetic Application
    • 8.6.6. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Biopharma Companies
    • 8.7.2. Contract Research Organizations
    • 8.7.3. Academic Research Institutes
    • 8.7.4. Diagnostic Laboratories
    • 8.7.5. Food Industry
    • 8.7.6. Cosmetic Industry
    • 8.7.7. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Recombinant Proteins Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Recombinant Protein Expression Systems
    • 9.2.4. By Application
    • 9.2.5. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Hormones
    • 9.4.2. Cytokines and Growth Factors
    • 9.4.3. Immune Checkpoint Proteins
    • 9.4.4. Metabolic Enzymes
    • 9.4.5. Antibodies
    • 9.4.6. Regulatory Proteins
    • 9.4.7. Structural Proteins
    • 9.4.8. Collagen
    • 9.4.9. Others
  • 9.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
    • 9.5.1. Mammalian Expression Systems
    • 9.5.2. Bacterial Expression Systems
    • 9.5.3. Yeast Expression Systems
    • 9.5.4. Insect Cells Expression Systems
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Biomedical Research
    • 9.6.2. Diagnostics and Therapeutics
    • 9.6.3. Drug Discovery and Development
    • 9.6.4. Food Application
    • 9.6.5. Cosmetic Application
    • 9.6.6. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Biopharma Companies
    • 9.7.2. Contract Research Organizations
    • 9.7.3. Academic Research Institutes
    • 9.7.4. Diagnostic Laboratories
    • 9.7.5. Food Industry
    • 9.7.6. Cosmetic Industry
    • 9.7.7. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Recombinant Proteins Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Recombinant Protein Expression Systems
    • 10.2.4. By Application
    • 10.2.5. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Hormones
    • 10.4.2. Cytokines and Growth Factors
    • 10.4.3. Immune Checkpoint Proteins
    • 10.4.4. Metabolic Enzymes
    • 10.4.5. Antibodies
    • 10.4.6. Regulatory Proteins
    • 10.4.7. Structural Proteins
    • 10.4.8. Collagen
    • 10.4.9. Others
  • 10.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
    • 10.5.1. Mammalian Expression Systems
    • 10.5.2. Bacterial Expression Systems
    • 10.5.3. Yeast Expression Systems
    • 10.5.4. Insect Cells Expression Systems
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Biomedical Research
    • 10.6.2. Diagnostics and Therapeutics
    • 10.6.3. Drug Discovery and Development
    • 10.6.4. Food Application
    • 10.6.5. Cosmetic Application
    • 10.6.6. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Biopharma Companies
    • 10.7.2. Contract Research Organizations
    • 10.7.3. Academic Research Institutes
    • 10.7.4. Diagnostic Laboratories
    • 10.7.5. Food Industry
    • 10.7.6. Cosmetic Industry
    • 10.7.7. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Recombinant Proteins Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Recombinant Protein Expression Systems
    • 11.2.4. By Application
    • 11.2.5. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Hormones
    • 11.4.2. Cytokines and Growth Factors
    • 11.4.3. Immune Checkpoint Proteins
    • 11.4.4. Metabolic Enzymes
    • 11.4.5. Antibodies
    • 11.4.6. Regulatory Proteins
    • 11.4.7. Structural Proteins
    • 11.4.8. Collagen
    • 11.4.9. Others
  • 11.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
    • 11.5.1. Mammalian Expression Systems
    • 11.5.2. Bacterial Expression Systems
    • 11.5.3. Yeast Expression Systems
    • 11.5.4. Insect Cells Expression Systems
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Biomedical Research
    • 11.6.2. Diagnostics and Therapeutics
    • 11.6.3. Drug Discovery and Development
    • 11.6.4. Food Application
    • 11.6.5. Cosmetic Application
    • 11.6.6. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Biopharma Companies
    • 11.7.2. Contract Research Organizations
    • 11.7.3. Academic Research Institutes
    • 11.7.4. Diagnostic Laboratories
    • 11.7.5. Food Industry
    • 11.7.6. Cosmetic Industry
    • 11.7.7. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Recombinant Proteins Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product Type
    • 12.2.3. By Recombinant Protein Expression Systems
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
    • 12.4.1. Hormones
    • 12.4.2. Cytokines and Growth Factors
    • 12.4.3. Immune Checkpoint Proteins
    • 12.4.4. Metabolic Enzymes
    • 12.4.5. Antibodies
    • 12.4.6. Regulatory Proteins
    • 12.4.7. Structural Proteins
    • 12.4.8. Collagen
    • 12.4.9. Others
  • 12.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
    • 12.5.1. Mammalian Expression Systems
    • 12.5.2. Bacterial Expression Systems
    • 12.5.3. Yeast Expression Systems
    • 12.5.4. Insect Cells Expression Systems
    • 12.5.5. Others
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.6.1. Biomedical Research
    • 12.6.2. Diagnostics and Therapeutics
    • 12.6.3. Drug Discovery and Development
    • 12.6.4. Food Application
    • 12.6.5. Cosmetic Application
    • 12.6.6. Others
  • 12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Biopharma Companies
    • 12.7.2. Contract Research Organizations
    • 12.7.3. Academic Research Institutes
    • 12.7.4. Diagnostic Laboratories
    • 12.7.5. Food Industry
    • 12.7.6. Cosmetic Industry
    • 12.7.7. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Thermo Fisher Scientific, Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Merck KGaA
    • 13.3.3. Sino Biological
    • 13.3.4. GenScript
    • 13.3.5. Bio-Rad Laboratories, Inc
    • 13.3.6. STEMCELL Technologies
    • 13.3.7. FUJIFILM Irvine Scientific
    • 13.3.8. Rockland Immunochemical
    • 13.3.9. ACROBiosystems
    • 13.3.10. Miltenyi Biotec
    • 13.3.11. Bio-Techne
    • 13.3.12. Proteintech Group, Inc.
    • 13.3.13. Enzo Biochem Inc.
    • 13.3.14. RayBiotech, Inc.
    • 13.3.15. BioLegend, Inc.
    • 13.3.16. Abcam Limited
    • 13.3.17. SYNBIO Technologies
    • 13.3.18. BPS Bioscience, Inc.
    • 13.3.19. Revvity
    • 13.3.20. Creative BioMart
    • 13.3.21. G-Biosciences (Geno Technology Inc.)
    • 13.3.22. Bioxcell
    • 13.3.23. Corning Incorporated
    • 13.3.24. Biosensis Pty Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations